$PBIO Measurable success achieved in Q3 2020 in ke
Post# of 8477
(Total Views: 209)
Posted On: 11/28/2020 9:51:45 AM
$PBIO Measurable success achieved in Q3 2020 in key financial, operational, and technical projects
Revenue increases reported in products and services offerings; balance sheet improved with significant reduction in variable-rate debt
Q3 total revenue exceeded Q1 and Q2 total revenue combined
Company reported receipt of 12 pre-orders for the innovative BaroShear K45, which is on track to be released in mid-2021
Alliance with Leica Microsystems over PBI’s proprietary pressure cycling technology (“PCT”) platform has the potential to accelerate cancer R&D and subsequent drug development using an innovative tumor processing workflow https://www.networknewswire.com/pressure-bios...rong-2021/
Revenue increases reported in products and services offerings; balance sheet improved with significant reduction in variable-rate debt
Q3 total revenue exceeded Q1 and Q2 total revenue combined
Company reported receipt of 12 pre-orders for the innovative BaroShear K45, which is on track to be released in mid-2021
Alliance with Leica Microsystems over PBI’s proprietary pressure cycling technology (“PCT”) platform has the potential to accelerate cancer R&D and subsequent drug development using an innovative tumor processing workflow https://www.networknewswire.com/pressure-bios...rong-2021/
(0)
(0)